Repligen (RGEN) PT Raised to $175 at Barclays
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $165.53 -0.1%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Join SI Premium – FREE
Barclays analyst Luke Sergott raised the price target on Repligen (NASDAQ: RGEN) to $175.00 (from $160.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Hyperion DeFi, Inc. (HYPD) PT Raised to $7.10 at Cantor Fitzgerald
- OptimizeRX (OPRX) PT Lowered to $12 at Stifel, Buy Rating Maintained
- Cisco (CSCO) PT Raised to $138 at UBS on Profit Growth Expectations
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
